New Delhi, Jun 25 (PTI) — A recent study has shed light on the immense psychological trauma and social exclusion faced by individuals suffering from vitiligo, a skin condition marked by the loss of pigmentation resulting in white patches. The research reveals that nearly all patients interviewed experience embarrassment about their appearance, with over half abstaining from social gatherings altogether. The study was based on insights from 430 government employees in Maharashtra living with vitiligo, highlighting a compelling dimension of the condition's impact beyond dermatology.
Published in the Annals of Plastic and Reconstructive Surgery in January, the study underscores the profound emotional toll taken by vitiligo. Led by Dr. Rinky Kapoor and Dr. Debraj Shome of The Esthetic Clinics, the research used four internationally validated psychometric scales to measure the psychological impact experienced by the participants. These include the Dermatology Life Quality Index (DLQI) and the Vitiligo Impact Scale-22 (VIS-22), among others.
The findings reveal alarming statistics: 60.5% of the surveyed individuals reported feelings of depression, 43.3% had contemplated suicide, and all participants expressed that their condition hindered their social interactions. Additionally, 71.9% reported that vitiligo affected their professional or academic life. "These aren't just numbers," Dr. Kapoor emphasized, warning of the unacceptable scale of suffering that is exacerbated by societal ignorance and stigma rather than its medical severity.
The research highlighted that 81.2% of participants experience significant stigma, as a large part of society mistakenly believes vitiligo to be contagious. The stigma is particularly harsh on women, affecting their prospects in marriage, career, and social avenues. "This is not just a dermatological issue but a social emergency," Dr. Kapoor asserted.
She noted that despite urban education, many families continue to view vitiligo with bias, leading to situations where individuals are ostracized in workplaces, marriages, and public spaces. Given that more than 40% of patients have considered ending their lives, Dr. Kapoor urged the need for increased public awareness, psychological aid, and societal inclusion, alongside medical interventions.
With vitiligo remaining medically benign, new treatment approaches like Janus Kinase (JAK) inhibitors, studied in a second research piece by Dr. Kapoor and Dr. Shome published in the Dermatological Reviews, show promise in managing symptoms. The study found significant improvements in patients using these in combination with narrowband UVB phototherapy.
However, clinical advancements will only yield sustainable progress if society changes its perception. Approximately 70 million people globally, including 8.8% of individuals in some Indian regions, live with the societal repercussions of vitiligo. "We need to build an ecosystem pairing medical care, psychological counselling, and public education," Dr. Kapoor concluded, highlighting that for many patients, the most profound scars are invisible.
(Only the headline of this report may have been reworked by Editorji; the rest of the content is auto-generated from a syndicated feed.)